Solesence (NASDAQ:SLSN - Get Free Report)'s stock had its "hold (c)" rating restated by equities researchers at Weiss Ratings in a report released on Wednesday,Weiss Ratings reports.
Separately, Wall Street Zen upgraded shares of Solesence from a "sell" rating to a "hold" rating in a research report on Sunday, August 3rd. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company currently has an average rating of "Hold".
Read Our Latest Analysis on Solesence
Solesence Trading Up 6.2%
Shares of NASDAQ:SLSN opened at $3.76 on Wednesday. The stock has a market cap of $265.00 million, a P/E ratio of 53.71 and a beta of 0.94. The company has a quick ratio of 0.84, a current ratio of 1.72 and a debt-to-equity ratio of 0.58. Solesence has a twelve month low of $1.26 and a twelve month high of $16.56. The business's 50 day moving average is $3.44.
Solesence (NASDAQ:SLSN - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The company reported $0.04 earnings per share for the quarter. The business had revenue of $20.36 million during the quarter. Solesence had a net margin of 8.13% and a return on equity of 32.99%.
Institutional Trading of Solesence
A number of large investors have recently bought and sold shares of the business. Modern Wealth Management LLC acquired a new stake in Solesence during the 2nd quarter worth $119,000. Bank of America Corp DE acquired a new stake in Solesence during the 2nd quarter worth $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in Solesence during the 2nd quarter worth $45,000. New York State Common Retirement Fund acquired a new stake in Solesence during the 2nd quarter worth $95,000. Finally, JPMorgan Chase & Co. acquired a new stake in Solesence during the 2nd quarter worth $39,000. Institutional investors and hedge funds own 70.22% of the company's stock.
Solesence Company Profile
(
Get Free Report)
Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Solesence, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Solesence wasn't on the list.
While Solesence currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
